Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma
- 1 March 1997
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 91 (3) , 135-142
- https://doi.org/10.1016/s0954-6111(97)90049-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- CYFRA 21-1: A new marker in lung cancerCancer, 1993
- Clinical Applications of Serum Tumor MarkersAnnals of Internal Medicine, 1991
- Usefulness of Tissue Polypeptide Antigen in Staging, Monitoring, and Prognosis of Lung CancerChest, 1988
- Looking for a functionNature, 1987
- Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9Cancer, 1987
- Clinical value of a multiple biomarker assay in patients with bronchogenic carcinomaCancer, 1986
- The role of serum tumour markers to aid the selection of lung cancer patients for surgery and the assessment of prognosisEuropean Journal of Cancer and Clinical Oncology, 1985
- Evaluation of a radioimminoassay for neuron specific enolase in small cell lung cancerBritish Journal of Cancer, 1985
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsPublished by Elsevier ,1982
- The value of carcinoembryonic antigen in patients with carcinoma of the lungCancer, 1979